Adaptimmune Therapeutics ADAPY
OTC ADAPY
$0.03 +0.00 (+0.00%)
At close: Oct 22, 2026 · 4:00 PM EDT

Adaptimmune Therapeutics PLC (ADAPY) Non-Current Debt (2024 - 2025)

Updated

Adaptimmune Therapeutics' Non-Current Debt was $25.68 million in Q2 2025, up 2.9% from $24.95 million a year earlier and up 1.0% from the prior quarter.

Analysis

Adaptimmune Therapeutics PLC (ADAPY) Non-Current Debt (2024 - 2025) Analysis & Trends

At the end of FY2024, Non-Current Debt at Adaptimmune Therapeutics came in at $50.24 million.

  • Quarterly Non-Current Debt has moved between $24.95 million (Q2 2024) and $50.24 million (Q4 2024) over five years.
  • Per Business Quant data, ADAPY's Non-Current Debt in the three quarters before Q2 2025 was $25.41 million (Q1 2025), $50.24 million (Q4 2024) and $49.87 million (Q3 2024).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 25.68 Mn
Mar 31, 2025 25.41 Mn
Dec 31, 2024 50.24 Mn
Sep 30, 2024 49.87 Mn
Jun 30, 2024 24.95 Mn
API Access

Adaptimmune Therapeutics PLC Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=ADAPY&period=max&api_key=YOUR_API_KEY